Systagenix Wound Management Limited：市場シェア分析...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
3 Definitions of Markets/Categories Covered 8
3.1 Wound Care Management 8
3.1.1 Advanced Wound Management 8
4 Company Snapshot 9
4.1 Key Information 9
4.2 Company Overview 9
4.3 SWOT Snapshot 9
4.4 Business Overview 10
4.5 Major Products and Services 11
4.5.1 Overview 11
5 History 12
6 SWOT Analysis 13
6.1 Overview 13
6.2 Systagenix Wound Management Limited Strengths 14
6.2.1 Focused Research and Development Activities 14
6.2.2 Wide Geographical Presence 14
6.2.3 Broad Product Portfolio 14
6.3 Systagenix Wound Management Limited Weaknesses 14
6.3.1 Single Manufacturing Facility 14
6.3.2 Incidences of Product Recalls 14
6.4 Systagenix Wound Management Limited Opportunities 15
6.4.1 Growing Wound Care Market 15
6.4.2 Growing Aged Population 15
6.4.3 Growth Potential in Emerging Economies 15
6.5 Systagenix Wound Management Limited Threats 16
6.5.1 Stringent Government Regulations 16
6.5.2 Cost Containment Pressures 16
6.5.3 Risk of Product Obsolescence 16
7 Competitors 17
8 Competitive Landscape 18
8.1 Wound Care Management (Advanced Wound Management), Global, Market Share (%), 2011 18
8.2 Systagenix Wound Management Limited, Wound Care Management (Advanced Wound Management )by Region, Market Share (2011) 20
8.3 Systagenix Wound Management Limited, Wound Care Management (Advanced Wound Management ), by Country, Market Share (2011) 21
9 Key Employees 23
10 Key Employee Biographies 24
11 Company Statement 26
12 Locations And Subsidiaries 27
12.1 Head Office 27
12.2 Other Locations & Subsidiaries 27
13 Systagenix Wound Management Limited Detailed Deal Summary 29
13.1 Partnerships 29
13.1.1 ECI Biotech Enters Into An Agreement With Systagenix Wound Management 29
13.1.2 MiMedx Enters Into Distribution Agreement With Systagenix Wound Management For EpiFix 30
13.1.3 Systagenix Wound Management Enters Into Co-Development Agreement With Alere 31
13.2 Acquisition 32
13.2.1 Systagenix Acquires O2 Insights 32
14 Recent Developments 33
14.1 Strategy And Business Planning 33
14.1.1 Dec 04, 2009: Systagenix Establishes Its Americas Headquarters In Quincy, Massachusetts 33
14.1.2 Aug 04, 2009: Systagenix Opens New Head Office At Gatwick 34
14.2 Corporate Communications 35
14.2.1 Jul 26, 2011: Systagenix Appoints Joe Woody To Board 35
14.2.2 Jun 06, 2011: Systagenix Appoints Ernest Waaser As New CEO 35
14.2.3 Oct 08, 2009: Systagenix Appoints Robert Snyder As Medical Director 36
14.3 Product News 36
14.3.1 Sep 04, 2012: Systagenix’s Woundchek Helps Transform Non-healing Wound Care 36
14.3.2 Aug 21, 2012: Systagenix Launches New ADAPTIC DIGIT In Brazil 37
14.3.3 Aug 21, 2012: Systagenix Launches New SILVERCEL NON-ADHERENT In Brazil 37
14.3.4 May 29, 2012: New Consensus On Appropriate Usage Of Silver Wound Dressings Launched: Systagenix 37
14.3.5 Apr 03, 2012: Systagenix Receives 2012 Award For Innovation And Technology For WOUNDCHEK Protease Status 38
14.3.6 Jan 24, 2012: Systagenix Announces CE Mark And First Commercial Shipment Of WOUNDCHEK Protease Status 38
14.3.7 Nov 15, 2011: Systagenix To Launch WOUNDCHEK Protease Status 39
14.3.8 Apr 20, 2011: Systagenix Annoucnes Publication Of Clinical Effectiveness Of ADAPTIC TOUCH Non-Adherent Dressing 40
14.3.9 Dec 02, 2010: Systagenix Launches ADAPTIC TOUCH Non-Adhering Silicone Dressing 40
14.3.10 Oct 23, 2009: Systagenix Launches SILVERCEL Non-Adherent Silver Hydro Alginate Dressing 40
14.4 Clinical Trials 41
14.4.1 Apr 20, 2011: Systagenix Annoucnes Publication Of Clinical Effectiveness Of ADAPTIC TOUCH Non-Adherent Dressing 41
14.5 Other Significant Developments 42
14.5.1 Jun 07, 2011: Systagenix Introduces WOUNDCHEK Brand At EWMA 2011 In Belgium 42
15 Appendix 43
15.1 Research Methodology 44
15.2 Secondary Research 44
15.3 Primary Research 44
15.4 Models 45
15.5 Forecasts 45
15.6 Expert Panels 45
15.7 GlobalData Consulting 45
15.8 Currency Conversion 46
15.9 Contact Us 47
15.10 Disclaimer 47